Pharmacia Device/Diagnostics Unit Ripe For Picking, Pfizer Says
This article was originally published in The Gray Sheet
Executive Summary
Pfizer's July 1 announcement that it will explore strategic options for divesting Pharmacia's device and diagnostics division confirms the company's intentions to shed non-core assets